June 11-12, 2012 | San Antonio, TX

ABOUT THE FORUM

The Life Science industry faces a large number of challenges when addressing their tax liabilities, on both a domestic and international playing field. Combined with increasing pressure from boards to reduce costs and expenditures, restricted pipelines and tremendous pressure from healthcare payers, tax executives have been pushed to the forefront of importance and are now seen as a major player in reducing overall spend. While a number of organizations have been lauded or vilified as being experts at reducing tax liabilities, for many organizations the immense number of opportunities and tax structures are daunting. As federal, state and local legislation continues to look towards industry as a viable source of tax revenue, the industry must be prepared to forecast and plan for potential tax increases. On an international level, organizations must also plan for greater scrutiny of transfer-pricing as the IRS continues their investigations of this key tax challenge.

From increasing tax rates applied to medical devices to repatriation taxes on international revenues, this program will cover a wide variety of the pressing challenges faced by the industry in today's economic environment. Breakout sessions will provide various industries the opportunity to discuss in detail through small group discussions the opportunities and challenges that they face in remaining profitable in this ever increasingly tax driven environment. Having a thorough understanding of the various liabilities and the many ways of reducing tax payments is essential. Given the increasing legal complexity of many tax frameworks, having the opportunity to come together as an industry and discuss taxation will be an incredibly valuable experience.

CPE CREDITS: This forum has been approved as 15 CPE Credits

TOPICS TO INCLUDE:

• Bridging the Gap between Tax Executives & the Executive Board
• Establishing a Tax-Efficient Repatriation Plan
• IRS Update: the IRS' International Realignment and its Impact on the Life Science Industry
• Industry Perspectives & Debate on the Revised IRS International Tax Strategy
• Distinguishing Evolving Trends within Life Science Tax Audits
• Schedule UTP: Preparing for the IRS Implementation
• Recognizing the Impact of Legislative Tax Changes on the Life Science Industry
• Healthcare Reform and the Implementation of the Medical Device Excise Tax
• Deciphering the Patient Protection and Affordable Care Act and the Pharmaceutical Excise Tax
• Managing Tax Requirements within Multiple State Jurisdictions
• Recognizing and Utilizing Life Science Tax Credits & Incentives
• Developing a Proficient Tax Planning Strategy for Mergers, Acquisitions & Divestitures
• International Tax Planning Strategies for Expanding Life Science Companies
• Working within an Evolving International Tax Framework
• Comprehensive Review of Global Transfer Pricing in the Life Science Industry
• Selected Intellectual Property Migration Strategies within a Tax/Manufacturing Partnership
• Successful Industry Approaches to Transfer Pricing
• Best Practices in Planning and Managing Tax-Effective Supply Chains
• Mitigating Tax Risk through Interdepartmental Communication Strategies
• Meeting Tax Documentation Requirements in a Global Industry
• Reducing Redundancies in Tax Management through System Automation
• Recent Trends and Developments within Advance Pricing Agreements

| And More |

Add to Calendar

KEY PRESENTERS TO INCLUDE:

Sam Maruca
Director, Transfer Pricing Operations
US Internal Revenue Service (IRS)

Stijn Ehren
Senior Director of International Tax
Merck, Sharp & Dohme

Bradley Shumaker
Tax Counsel, Transfer Pricing
Zimmer, Inc.

Joseph McGowan
Vice President of Tax
Hill-Rom

Marty Clemens
Senior Director, Global Tax
Eli Lilly

Frank Rork
Senior Director of International Tax
Edwards Lifesciences LLC

| And More |